Autolus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.About AUTL
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.
CEOChristian Martin Itin
CEOChristian Martin Itin
Employees752
Employees752
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2018
Founded2018
Employees752
Employees752
AUTL Key Statistics
Market cap391.25M
Market cap391.25M
Price-Earnings ratio-1.35
Price-Earnings ratio-1.35
Dividend yield—
Dividend yield—
Average volume1.61M
Average volume1.61M
High today$1.54
High today$1.54
Low today$1.38
Low today$1.38
Open price$1.48
Open price$1.48
Volume1.57M
Volume1.57M
52 Week high$2.70
52 Week high$2.70
52 Week low$1.18
52 Week low$1.18
AUTL News
Investing.com 18h
Autolus Therapeutics releases annual report and schedules shareholder meeting - Investing.com...
TipRanks 18h
Autolus Schedules 2026 AGM and Engages ADS HoldersAutolus Therapeutics ( (AUTL) ) has shared an update. On June 5, 2026, Autolus Therapeutics published its UK Annual Report and Accounts for the year ended Dece...
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.